VEGF Inhibitors and Prostate Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1874-4702|2|2|161-168

ISSN： 1874-4672

Source： Current Molecular Pharmacology, Vol.2, Iss.2, 2009-06, pp. : 161-168

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

VEGF Inhibitors in Cancer Therapy

By  

Current Pharmaceutical Design, Vol. 12, Iss. 3, 2006-01 ,pp. : 387-394

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging VEGF-receptor inhibitors for colorectal cancer

By Martinelli Erika   Troiani Teresa   Morgillo Floriana   Orditura Michele   De Vita Fernando   Belli Giulio   Ciardiello Fortunato  

Expert Opinion on Emerging Drugs, Vol. 18, Iss. 1, 2013-03 ,pp. : 25-37

Informa Healthcare

Access to resources Recommend Favorite

Angiogenesis inhibitors in the treatment of prostate cancer

By Kluetz Paul G   Figg William D   Dahut William L  

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 2, 2010-02 ,pp. : 233-247

Informa Healthcare

Access to resources Recommend Favorite

Proteasome Inhibitors in Cancer Therapy

By  

Current Drug Targets, Vol. 10, Iss. 10, 2009-10 ,pp. : 968-981

Bentham Science Publishers

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A   Golijanin Dragan J   Miyamoto Hiroshi   Messing Edward M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite